Update on Issue of Equity

Summary by AI BETAClose X

Brave Bison Group PLC has announced a slight delay in the admission of 202,451 new Ordinary Shares, which were to be issued pursuant to the exercise of options by certain Group employees. The admission, previously announced for 12 December 2025, is now scheduled for 23 December 2025, with all other details remaining unchanged.

Disclaimer*

Brave Bison Group PLC
19 December 2025
 

 

 

Brave Bison Group plc

 

("Brave Bison" or the "Company", together with its subsidiaries "the Group") 

 

Update on Issue of Equity

 

Brave Bison, the next-generation marketing and technology partner for global brands, announces that further to the announcement made on 12 December 2025, Admission of the 202,451 new Ordinary Shares pursuant to the exercise of options by certain Group employees will now take place on 23 December 2025. All other details remain unchanged.

 

For further information please contact: 

 

Brave Bison Group plc 

Oliver Green, Chairman                                                                          via Cavendish

Theo Green, Chief Growth Officer 

Philippa Norridge, Chief Financial Officer 

 

Cavendish Capital Markets                                                                     Tel: +44 (0) 20 7220 0500 

Nominated Adviser & Joint Broker  

Ben Jeynes / Teddy Whiley / Elysia Bough - Corporate Finance 

Michael Johnson / Sunila de Silva - ECM 

 

Singer Capital Markets                                                                              Tel: +44 (0) 20 7496 3000

Joint Broker

Alex Hardwicke

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Brave Bison Group (BBSN)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today